BiotechTube
Home/Pipeline/EXO‑Ovarian Cancer Test

EXO‑Ovarian Cancer Test

Ovarian Cancer

Phase 2/3Active

Key Facts

Indication
Ovarian Cancer
Phase
Phase 2/3
Status
Active
Company
INOVIQ

About INOVIQ

Australian cancer‑diagnostics and exosome‑therapeutics company with commercial assays and a growing pipeline.

View full company profile

Therapeutic Areas

Oncology

Other Ovarian Cancer Drugs

DrugCompanyPhase
CAR‑iNK‑OvCaCarthericsPreclinical
MagSense™ FR Imaging AgentImagion BiosystemsPre‑clinical
Yondelis (trabectedin)PharmaMarApproved
Measovir®-based candidateOncovitaPre-clinical
NP-G2-044 + Chemotherapy AgentsNovita PharmaceuticalsPhase 2a
Ivospemin (SBP-101)Panbela TherapeuticsPhase 2
Ovarian Cancer Early Detection AssayGenEndeavorPre-clinical
INVAC-1InvectysPhase 2
Folate Receptor-Targeted PCCIndi MolecularPreclinical
Immunomodulator PlatformOmniCytePre-clinical
Platform CandidateFLAG TherapeuticsPreclinical
High Internalization ADCLytica TherapeuticsPreclinical